Brent W. Johnston, MBA
Madison, Wisconsin, United States
3K followers
500+ connections
About
I am a Senior executive with a successful record of accomplishment implementing and…
Articles by Brent W.
-
Exsomed has a new office, now located at 7227 N. 16th St. Phoenix AZ 85020
Exsomed has a new office, now located at 7227 N. 16th St. Phoenix AZ 85020
2 Comments -
Exsomed is hiring...
Exsomed is hiring...
Looking for talented design engineers with 3-5 yrs experience in orthopedic device/implant. Send resume's to…
Activity
-
Love me some Halloween with the Brand it group!!
Love me some Halloween with the Brand it group!!
Liked by Brent W. Johnston, MBA
-
As I transition from my current position, I want to take a moment to reflect on the incredible year I've had in the wholesale apparel industry. I had…
As I transition from my current position, I want to take a moment to reflect on the incredible year I've had in the wholesale apparel industry. I had…
Liked by Brent W. Johnston, MBA
-
Finally starting to feel like Fall in New Jersey as Halloween approaches 🎃 Great day to rock the new Stratos Private Wealth gear and an even better…
Finally starting to feel like Fall in New Jersey as Halloween approaches 🎃 Great day to rock the new Stratos Private Wealth gear and an even better…
Liked by Brent W. Johnston, MBA
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Volunteer Experience
Projects
-
American College of Healthcare Executives- Member (Becoming a Fellow)
The American College of Healthcare Executives is the professional society for healthcare leaders committed to improving health.
-
Toronto Securities Exchange (TSX) Venture: IPO
-
I am pleased to announce that Aurora Spine Corporation ("Aurora Spine") has completed its previously announced initial public offering (IPO). We are very proud to have completed our IPO so successfully and to become a public company on the TSX Venture Exchange. This is an important corporate milestone for Aurora Spine, one that we hope will accelerate our position as a global innovator in regenerative spinal implant technologies.
TSX Venture Exchange
Stock symbol: ASG
The…I am pleased to announce that Aurora Spine Corporation ("Aurora Spine") has completed its previously announced initial public offering (IPO). We are very proud to have completed our IPO so successfully and to become a public company on the TSX Venture Exchange. This is an important corporate milestone for Aurora Spine, one that we hope will accelerate our position as a global innovator in regenerative spinal implant technologies.
TSX Venture Exchange
Stock symbol: ASG
The TSX Venture Exchange is a stock exchange in Canada. It is headquartered in Calgary, Alberta and has offices in Toronto, Vancouver, and Montreal. As of November 2010, the TSX Venture Exchange had 2,364 listed companies with a combined market capitalization of $60,811,203,235.Other creators -
-
American Heart Association
-
Board of Directors
More activity by Brent W.
-
Just wrapped up an inspiring trip to Europe with our incredible INSIGHTEC European leadership team and our valued distributor partner,Palex España…
Just wrapped up an inspiring trip to Europe with our incredible INSIGHTEC European leadership team and our valued distributor partner,Palex España…
Liked by Brent W. Johnston, MBA
-
On this Boss’s Day, some of the team members at Morton Plant North Bay Hospital wanted to recognize hospital president Brandon May for his…
On this Boss’s Day, some of the team members at Morton Plant North Bay Hospital wanted to recognize hospital president Brandon May for his…
Liked by Brent W. Johnston, MBA
-
It’s #MilestoneMonday! Today we are excited to shout out the amazing team at Stanford Neurosurgery, one of the pioneer sites during early trials of…
It’s #MilestoneMonday! Today we are excited to shout out the amazing team at Stanford Neurosurgery, one of the pioneer sites during early trials of…
Liked by Brent W. Johnston, MBA
-
This Nuclear Medicine Week, we continue to push the boundaries of molecular imaging. At Siemens Healthineers, we recognize the innovative technology…
This Nuclear Medicine Week, we continue to push the boundaries of molecular imaging. At Siemens Healthineers, we recognize the innovative technology…
Liked by Brent W. Johnston, MBA
-
The Becker’s article on IT outsourcing highlights a key issue—how can health systems keep pace with technology demands without overburdening their…
The Becker’s article on IT outsourcing highlights a key issue—how can health systems keep pace with technology demands without overburdening their…
Liked by Brent W. Johnston, MBA
Other similar profiles
Explore more posts
-
Kingsley R. Chin MD MBA, CEO Spine Surgeon Professor Author
Some cadaveric educational skills labs are worth posting. Today in Ohio I had a surprised visit by Dr. Josue Gabriel, MD a fellow Bohlman fellow trained Orthopedic Spine Surgeon and co-founder. We designed a lot of products together since 2007 and today we revisited FacetFuse and how slick it was to be the first to introduce power drills, taps and screw driver in 2008-9 for transfacet pedicle screws. Angel Walker and I are usually on different coasts today he popped in by special request from Abdul Shahid for a Sacrix case tomorrow. The movement is building at the grassroots state by state, city by city and doctor by doctor willing to change the future today. Thanks for hosting us Dr Mehta. LESS is More. LESS Exposure Spine Surgery Learn more: www.NANISX.com Invest with us to make: LESS Exposure Advanced Spine Technologies (LEAST) Be a member. Be an owner. Invest. www.KICventures.com KIC Ventures NANISX Inspan Sacrix FacetFuse NanoFUSE Biologics MISquito #LESS #LESSExposure #Spine #surgery #invest #Orthopedic
-
Chandler Holderness
Repswear 101…..20yr old construct removals. At Alliance Medical LLC we always try to get imaging at least 3 days before a revision case to leverage our network to identify the hardware. Sometimes, we fail and cannot identify the hardware. So what’s your move? Hope universal removal set can get it out and deal with the docs frustration then?….bring in multiple companies best guess at it?…give the doctor the excuse ahead of time? What would a surgeon prefer? Curious to hear everyone’s play on this. Side note: there are actually a few docs out there that enjoy the challenge of figuring out how to removal obsoleted hardware. Lali Sekhon, MD PhD MBA Jameil ‘Jay’ Pendleton™ Daniel Tighe Caleb Granger Matt Cieply Joshua Taggart Zavation Medical Products, LLC SeaSpine Orthofix Centinel Spine Highridge Medical Precision Spine Innovasis, Inc. Kyocera Medical Technologies, Inc. Accelus Darkwater Consulting
39 Comments -
Jim Ferch
Don’t miss out on the future of surgery center efficiency! See it in action [https://lnkd.in/eAWsXypg ] Looking for a better way to manage implant tracking and vendor communication? SimplifyOR is leading the way by seamlessly integrating with ENVI in real-time. This integration connects implant manufacturers, vendors, and surgery centers, fostering trust, transparency, and compliance across the board. Discover how SimplifyOR is elevating implant management. Stay ahead with smarter solutions for your surgery center! #Leadership #Innovation #Management #Technology #Healthcare #HealthTech #DigitalHealth #HealthcareInnovation #HealthcareSupplyChain #HealthSystems #ASC #Cardiology #HealthcareSupplyChain #BillOnlyOrders
-
Dr. Alan N. Glazier. OD, FAAO, Dipl. ABO
Consider this one-of-a-kind Rx eye drop for your patients with dry eye disease. MIEBO® is vehicle free, preservative free, steroid free, and water free.¹ It’s also the ONLY Rx eye drop to directly target tear evaporation.¹ See the difference here: bit.ly/43sOylY #sponsored MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease. IMPORTANT SAFETY INFORMATION •MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO •Instruct patients to instill one drop of MIEBO into each eye four times daily •The safety and efficacy in pediatric patients below the age of 18 have not been established •The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness) You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information at MIEBO-ECP.COM. Reference: 1. MIEBO. Prescribing Information. Bausch & Lomb, Inc; 2023. ©2024 Bausch + Lomb MBO.0243.USA.24
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More